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Action Owner
Completion 
Date Status
Observe Pharmacy /Supply Chain drug and IV shortage meeting to
determine current gaps in drug/IV shortage management process
Stephen Tyzik 11/16/17 Completed
Develop a drug shortage prioritization matrix that the Pharmacy can use
to assess criticality and feed into a priority based communication pathway
Stephen Tyzik January 2018 Completed
Facilitate a meeting between Supply Chain and Pharmacy to outline gaps
in current process, triage the root causes and develop agreed upon action
plans/timelines/needed support to implement improvement strategies
Jason Tremblay and 
Stephen Tyzik
January 2018 Completed
Work with Supply Chain to develop an IV Fluid shortage prioritization
matrix that Supply Chain and Materials Management can use to assess
criticality and feed into a priority based communication pathway
Jason Tremblay, Rita 
Renaud, Jody Batsford, 
Katherine Anderson and 
Stephen Tyzik
February 2018 Completed
Baseline Metrics/Current State:
Countermeasures
Outcomes
In September of 2017, Hurricane Maria struck the island of Puerto Rico where over 50 pharmaceutical factories had 
previously operated. The impact of this was felt not only in the drastic reduction of products that are produced on the 
island such as Baxter’s mini-bags, but it also exacerbated  supply chain issues for key drugs nationwide. As Pharmacy 
team’s across the country raced to collect information and develop mitigation strategies for navigating these shortages, the 
need to streamline internal planning and communication is critical. At Maine Medical Center, the Pharmacy Department 
and Supply Chain did not have a consistent and reliable process for communication, planning and real-time updates. This 
yielded a tremendous amount of waste before, during and after the drug/IV shortage meeting. 
Problem/Impact Statement:
Scope:
1. To reduce the time of the twice-a-week Drug/IV Shortage Meeting from 75 minutes to 30 minutes
2. To reduce the time of the IV shortage discussion/planning from 35 minutes to < 10
3. To reduce the time of the drug shortage discussion/planning from 40 minutes to < 20
4. To eliminate 100% of unnecessary communication between the Pharmacy and Supply Chain outside of the  Drug/IV 
Shortage Meeting 
Goal/Objective:
Root Cause Analysis:
Continue to utilize prioritization matrix as Drug/IV Fluid shortages evolve and utilize similar process improvement 
strategies for challenges moving forward.
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Improving the Management of  Nationwide Drug and IV Bag Shortages
Last Updated: 9/21/2018  
Team Members: Inpatient Pharmacy and Supply Chain
Executive Sponsor: Mark Parker, MD Facilitator: Stephen Tyzik, Suneela Nayak, Ruth Hanselman and Amy Sparks 
In Scope: The workflows that Pharmacy/Supply Chain utilize to obtain and communicate the most up to date 
information for drug and IV shortages at the twice-a-week Drug/IV Shortage Meeting. 
Out of Scope: Out of scope will be all of the other workflows that Supply Chain and Pharmacy utilize to communicate 
with one another in between the meetings.
Previously, the inpatient Pharmacy team at Maine Medical Center did not have a robust process for efficiently managing 
the day to day information for all drugs considered to be on a “shortage”. Due to the number of people that needed to be 
at the meetings to assess severity and properly develop mitigation strategies, each meeting came at a cost of approximately 
$429.95. When multiplied by the number of meetings that occurred prior to the interventions, the resulting overall cost 
was between $20,637.60 and $23,733.24. 
FDA Strategies to 
Effectively Manage 
Drug Shortages
MMC Improvement Strategies (Implemented)
Develop and/or 
Streamline Internal 
Processes 
1. On a daily basis Supply Chain reviews items that drop below the re-order point and < 7 days supply on hand (SOH) which triggers 
communication to the Pharmacy and development of an internal and external mitigation strategy. Those > 7 days SOH are triaged for 
discussion at the twice a week Pharmacy/Supply Chain Drug Shortage Meeting.
2. On a daily basis Pharmacy utilizes a prioritization matrix (discussed below), any drugs that change to a red priority score with < 7 
days SOH trigger a mitigation strategy. Those > 7 day SOH get triaged to the Drug Shortage Meeting.
Improve Data and 
Response Tracking
On a daily basis, the Pharmacy updates their drug shortage spreadsheet which automatically updates a prioritization matrix so that key 
variables (SOH, re-supply ETA, daily usage) trigger the development of an appropriate mitigation strategy
Clarify 
Roles/Responsibility 
In conjunction with the streamlined processes above, a swimlane diagram was developed to articulate the roles of Supply Chain, 
Materials Management, Pharmacy and Risk and Patient Safety within the daily management of Drug/IV shortages.
Enhance Public 
Communications about 
Drug Shortages
In alignment with the development of the above mitigation strategies, each of the color codes on the prioritization matrix (Red, 
Orange, Yellow, Green) correspond to an associated communication plan. 
Develop Methods to 
Incentivize and 
Prioritize Quality
The Pharmacy/Supply Chain Drug Shortage Meeting experienced a > 250% reduction in minutes (35  < 10) which was dedicated to 
discussion/planning to manage IV fluid shortages and a 100% reduction in minutes (40  20) which was dedicated to 
discussion/planning to manage drug shortages.
Develop risk-based 
approaches to identify 
early warning to prevent 
supply disruptions.
For Supply Chain and Pharmacy, both of them have transformed their IV Fluid/Drug shortage management spreadsheets with 
prioritization driven visual management. In real time, the updating of multiple variables give them real time feedback to the urgency of 
a situation surrounding an IV fluid and/or drug. 
Implementation of  these strategies led to a meeting time of  24 minutes, which meets
the target and reduces the salary cost of  the meeting from $429.95 to $171.98
